Collaborative opportunities
At Werfen, we actively seek partnerships that can accelerate the development of next-generation diagnostic solutions. We welcome collaborations with academic institutions, biotech companies, startups, and technology providers in the following key areas.

Non-invasive diagnostics. Clinically tested biomarkers in peripheral fluids.
- Hemostasis
- Autoimmunity
- Transfusion
- Transplant
Diagnostics targets

- Affinity reagents - mAbs, recAb, chimeric antibodies, aptamers, peptides, DARPns, etc.
- Blocking agents & surfactants - BSA alternatives, heterophilic interaction blocking.
- Coupling and labelling agents - signal enhancers, crosslinking, protein orientation.
Biomaterials and reagents

- Protein purification
- Protein engineering
- Protein in-silico tools - for epitope mapping and protegin modelling
- Protein expression - e.g. microalgae, cell-free
Process technologies

- Biosensors and other platforms - point-of-need solutions and multiplexed assays.
- Detection technologies - including immunoassays, molecular diagnostics, innovative assay designs, small molecule detection, quasi-identical molecules, conformational biomarkers, extracellular vesicles.
Assay technologies
We are excited to explore new ideas and technologies with innovators around the world. If you have a proposal that fits within our strategic areas, please fill out the following form: